Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$708.84 - $794.68 $297,003 - $332,970
-419 Closed
0 $0
Q3 2021

Nov 08, 2021

SELL
$657.71 - $825.77 $251,245 - $315,444
-382 Reduced 47.69%
419 $313,000
Q2 2021

Aug 11, 2021

BUY
$576.64 - $649.04 $461,888 - $519,881
801 New
801 $523,000
Q1 2021

May 11, 2021

SELL
$547.01 - $662.35 $397,676 - $481,528
-727 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$510.68 - $643.45 $462,165 - $582,322
-905 Reduced 55.45%
727 $433,000
Q3 2020

Nov 09, 2020

BUY
$454.43 - $535.6 $24,084 - $28,386
53 Added 3.36%
1,632 $858,000
Q2 2020

Aug 10, 2020

SELL
$334.87 - $493.06 $196,568 - $289,426
-587 Reduced 27.1%
1,579 $712,000
Q1 2020

Apr 24, 2020

BUY
$320.01 - $409.07 $108,483 - $138,674
339 Added 18.56%
2,166 $761,000
Q4 2019

Feb 06, 2020

SELL
$319.73 - $374.2 $8,632 - $10,103
-27 Reduced 1.46%
1,827 $673,000
Q3 2019

Nov 01, 2019

SELL
$304.55 - $345.24 $447,993 - $507,848
-1,471 Reduced 44.24%
1,854 $617,000
Q2 2019

Aug 08, 2019

BUY
$286.93 - $312.59 $6,025 - $6,564
21 Added 0.64%
3,325 $1.04 Million
Q1 2019

May 09, 2019

BUY
$224.3 - $317.41 $114,617 - $162,196
511 Added 18.3%
3,304 $1.01 Million
Q4 2018

Feb 07, 2019

SELL
$220.1 - $309.0 $1,980 - $2,781
-9 Reduced 0.32%
2,793 $651,000
Q3 2018

Nov 01, 2018

BUY
$289.28 - $326.15 $11,860 - $13,372
41 Added 1.48%
2,802 $876,000
Q2 2018

Aug 01, 2018

BUY
$244.1 - $303.88 $265,336 - $330,317
1,087 Added 64.93%
2,761 $797,000
Q1 2018

May 07, 2018

BUY
$233.97 - $274.11 $164,714 - $192,973
704 Added 72.58%
1,674 $433,000
Q4 2017

Feb 09, 2018

BUY
$216.94 - $271.3 $867 - $1,085
4 Added 0.41%
970 $233,000
Q3 2017

Nov 13, 2017

BUY
$212.27 - $242.28 $205,052 - $234,042
966
966 $222,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.48B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.